Skip to content
← Full study record

NCT03018223 · OUTCOME

Incidence of Chronic GVHD

Calcineurin Inhibitor-Free GVHD Prevention Regimen After Related Haplo PBSCT · Source last updated 2021-09-16

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
percentage of participants
Interval / dispersion
95% Confidence Interval
Time frame
1 year post HCT

What was measured

Cumulative incidence of chronic GVHD by 1 year. Chronic GVHD diagnosis follow National Institutes of Health (NIH) Consensus guidelines.

Groups in this outcome

Conditioning/HCT/GVHD Prophylaxis

Pre-HCT Conditioning, HCT, GVHD Prophylaxis.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Conditioning/HCT/GVHD Prophylaxis32

Reported measurements

Source class 1
Values in percentage of participants · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Conditioning/HCT/GVHD Prophylaxis20.0Not reported7.936.0Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        7.9
        upper Limit
        36.0
        value
        20.0
denoms
  1. counts
    1. group Id
      OG000
      value
      32
    units
    Participants
description
Cumulative incidence of chronic GVHD by 1 year. Chronic GVHD diagnosis follow National Institutes of Health (NIH) Consensus guidelines.
dispersion Type
95% Confidence Interval
groups
  1. description
    Pre-HCT Conditioning, HCT, GVHD Prophylaxis.
    id
    OG000
    title
    Conditioning/HCT/GVHD Prophylaxis
param Type
NUMBER
reporting Status
POSTED
time Frame
1 year post HCT
title
Incidence of Chronic GVHD
type
SECONDARY
unit Of Measure
percentage of participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice